Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer

Two types of prognostic signatures for predicting recurrent risk of ER+ breast cancer patients have been developed: one type for patients accepting surgery only and another type for patients receiving post-operative tamoxifen therapy. However, the first type of signature cannot distinguish high-risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Hao, Li, Xiangyu, Li, Jing, Ao, Lu, Yan, Haidan, Tong, Mengsha, Guan, Qingzhou, Li, Mengyao, Guo, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792578/
https://www.ncbi.nlm.nih.gov/pubmed/26527319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792578/
https://www.ncbi.nlm.nih.gov/pubmed/26527319

Ejemplares similares